#immune-response

#immune-response

Research highlights a specific intestinal dendritic cell type that suppresses immune responses to food proteins, potentially paving the way for food allergy treatments.

A newly developed vaccine for early-stage breast cancer, given in three doses, aims to prevent progression of the disease.

Receiving a COVID-19 booster in the same arm as the first dose enhances immune response compared to the opposite arm.

Scratching a mosquito bite activates an immune response that protects skin, explaining why it feels satisfying.

Scratching an itch may have both harmful and beneficial effects, suggesting an evolutionary basis for the behavior.

T cells play a crucial role in the immune response to COVID-19 and should not be overlooked in vaccine studies.

Lag3 expression in regulatory T-cells is critical for preventing autoimmune inflammation and may be a target for therapies in inflammatory conditions and cancer.

A newly identified γδ T cell-IL-3 signaling pathway governs sensory neuron responses to allergens, impacting allergic susceptibility and potential treatments.

Mosquito bites cause itchy welts due to saliva injected by females, which stimulates an immune response leading to inflammation.

Immune cells promote deep sleep post-heart attack, facilitating recovery by reducing inflammation.

Abnormally high levels of enzyme Olah found in seriously ill patients with common respiratory viruses may lead to severe infections and inflammation.

Mitochondria influence immune response by modulating cell signaling pathways, offering potential targets for treating inflammation-related diseases.

Inflammation in the heart can trigger immune responses even without immune cells, guiding myocarditis treatment.